Fast High‐Resolution Metabolite Mapping in the rat Brain Using 1H‐FID‐MRSI at 14.1 T
- 23 December 2024
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 38 (2) , e5304
Abstract
Magnetic resonance spectroscopic imaging (MRSI) enables the simultaneous noninvasive acquisition of MR spectra from multiple spatial locations inside the brain. Although 1H‐MRSI is increasingly used in the human brain, it is not yet widely applied in the preclinical setting, mostly because of difficulties specifically related to very small nominal voxel size in the rat brain and low concentration of brain metabolites, resulting in low signal‐to‐noise ratio (SNR). In this context, we implemented a free induction decay 1H‐MRSI sequence (1H‐FID‐MRSI) in the rat brain at 14.1 T. We combined the advantages of 1H‐FID‐MRSI with the ultra‐high magnetic field to achieve higher SNR, coverage, and spatial resolution in the rat brain and developed a custom dedicated processing pipeline with a graphical user interface for Bruker 1H‐FID‐MRSI: MRS4Brain toolbox. LCModel fit, using the simulated metabolite basis set and in vivo measured MM, provided reliable fits for the data at acquisition delays of 1.30 ms. The resulting Cramér–Rao lower bounds were sufficiently low (< 30%) for eight metabolites of interest (total creatine, N‐acetylaspartate, N‐acetylaspartate + N‐acetylaspartylglutamate, total choline, glutamine, glutamate, myo‐inositol, and taurine), leading to highly reproducible metabolic maps. Similar spectral quality and metabolic maps were obtained with one and two averages, with slightly better contrast and brain coverage due to increased SNR in the latter case. Furthermore, the obtained metabolic maps were accurate enough to confirm the previously known brain regional distribution of some metabolites. The acquisitions proved high reproducibility over time. We demonstrated that the increased SNR and spectral resolution at 14.1 T can be translated into high spatial resolution in 1H‐FID‐MRSI of the rat brain in 13 min using the sequence and processing pipeline described herein. High‐resolution 1H‐FID‐MRSI at 14.1 T provided robust, reproducible, and high‐quality metabolic mapping of brain metabolites with minimal technical limitations.Keywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (201218, 207935)
- Centre d'Imagerie BioMédicale
This publication has 33 references indexed in Scilit:
- Fast high‐resolution brain metabolite mapping on a clinical 3T MRI by accelerated H‐FID‐MRSI and low‐rank constrained reconstructionMagnetic Resonance in Medicine, 2018
- Density‐weighted concentric circle trajectories for high resolution brain magnetic resonance spectroscopic imaging at 7TMagnetic Resonance in Medicine, 2017
- Macromolecule mapping of the brain using ultrashort‐TE acquisition and reference‐based metabolite removalMagnetic Resonance in Medicine, 2017
- RF shimming for spectroscopic localization in the human brain at 7 TMagnetic Resonance in Medicine, 2009
- Comparison of T1 relaxation times of the neurochemical profile in rat brain at 9.4 tesla and 14.1 teslaMagnetic Resonance in Medicine, 2009
- Fat suppression for 1H MRSI at 7T using spectrally selective adiabatic inversion recoveryMagnetic Resonance in Medicine, 2008
- Quantitative proton spectroscopic imaging of the neurochemical profile in rat brain with microliter resolution at ultra‐short echo timesMagnetic Resonance in Medicine, 2007
- In Vivo NMR Spectroscopy2007
- Developmental and regional changes in the neurochemical profile of the rat brain determined by in vivo 1H NMR spectroscopyMagnetic Resonance in Medicine, 2003
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993